How many institutions own RNAZ stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own RNAZ shares is 11, representing 4.43% of the company's common stock.

Who are the major shareholders selling TransCode Therapeutics, Inc. stock?

CAHILL WEALTH MANAGEMENT, LLC, in the last quarter, reduced its stake in RNAZ by -100% restricting it's holding to 0 shares of worth nearly -. MORGAN STANLEY also lessened -100% of the RNAZ shares from its portfolio, reducing its holding to 0 shares of worth -. BLACKROCK INC. also shunned RNAZ shares holding by -91.17% last quarter which brought its holding to 1.39 thousand shares worth $469.00.

Investors who are buying RNAZ stock?

As per its latest 13F filing, SHEETS SMITH WEALTH MANAGEMENT increased its stake in RNAZ by 140% in the last quarter. The institutional holder raised its holding to 60 thousand shares having worth more than $20.31K. ONE68 GLOBAL CAPITAL, LLC also added 100% more shares of RNAZ to its portfolio, raising its holding to 30.12 thousand shares of worth $10.20K. WARBERG ASSET MANAGEMENT LLC also increased its RNAZ shares holding by 100% which brought its holding to 20 thousand shares worth $6.77K.

RNAZ's major insiders: who are they?

The insider with the most stakes in RNAZ is Dudley Robert Michael , Chief Executive Officer at the company. Additionally, RNAZ stock is highly held by Chief Financial Officer Fitzgerald Thomas A and N/A N/A among others.

Did an insider recently sell RNAZ stock?

Company executives, directors, and other insiders own 0.15% percent of TransCode Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which RNAZ insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased RNAZ stock?

There have been 0 transaction(s) during the past 6-months in which TransCode Therapeutics, Inc. insiders have bought stock, totalling 0 shares

How much of RNAZ does insiders own?

Around 0 TransCode Therapeutics, Inc. shares are held by insiders, which represents about 0.15% of RNAZ stock.

Who is the insider with the largest stake?

RNAZ Chief Executive Officer, Dudley Robert Michael holds the largest portfolio of the company's shares. RNAZ shares owned by Dudley total nearly 180.26 thousand.

Which institution holds the most shares in RNAZ?

CAHILL WEALTH MANAGEMENT, LLC is the largest institutional owner in RNAZ which holds 0 shares worth - or 0% of the total RNAZ shares outstanding followed by MORGAN STANLEY with ownership of 0 shares representing 0% of the RNAZ ownership. BLACKROCK INC. is the third largest stakeholder with 1.39 thousand shares or 0% of the ownership worth more than $469.00.

Is TransCode Therapeutics, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the RNAZ is concerned, it is a stock which is not optionable.

Is there a short position on RNAZ's shares?

Number of RNAZ shares short is 114.40K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding RNAZ shares are there?

As of today, 833.68K shares of RNAZ are outstanding.

Is there many float in RNAZ stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, RNAZ has 832.42K shares in float.

RNAZ short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for RNAZ is 0.52.

Stock Ideas

RNAZ Stock Ownership Breakdown

NASDAQ : RNAZ

TransCode Therapeutics

$8.01

0.08+1.01%

At Close 4:00 PM

66.72

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares13.72

Short Percent Of Float13.72

Shares Outstanding833.68K

Shares Float832.42K

Shares Short114.40K

Short Ratio0.52

13.72%

Short % of Float

13.72%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

0.15% Percentage of Shares held by All Insiders

4.43% Percentage of Shares held by All Institutions

4.44% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 4.43% of RNAZ shares are held by financial institutions. CAHILL WEALTH MANAGEMENT, LLC is the top corporate investor, holding 0 shares valued at -. A 0% stake in TransCode Therapeutics, Inc. is owned by the company. MORGAN STANLEY owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2023	CAHILL WEALTH MANAGEMENT, LLC	0%	0	-	-47.06K	-100.00%
Mar 31, 2023	MORGAN STANLEY	0%	0	-	-1.17K	-100.00%
Mar 31, 2023	BLACKROCK INC.	0%	1.39K	469	-14.29K	-91.17%
Mar 31, 2023	MILLENNIUM MANAGEMENT LLC	0%	0	-	-12.88K	-100.00%
Mar 31, 2023	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0%	0	-	-20.85K	-100.00%
Mar 31, 2023	HRT FINANCIAL LP	0%	0	-	-26K	-100.00%
Mar 31, 2023	VIRTU FINANCIAL LLC	0%	0	-	-16.36K	-100.00%
Mar 31, 2023	UBS GROUP AG	0%	0	-	-1.16K	-100.00%
Mar 31, 2023	TRIUMPH CAPITAL MANAGEMENT	0%	0	-	-10K	-100.00%
Mar 31, 2023	GEODE CAPITAL MANAGEMENT, LLC	0.03%	75.68K	25.64K	-866	-1.13%
Mar 31, 2023	SHEETS SMITH WEALTH MANAGEMENT	0.02%	60K	20.31K	35K	+140.00%
Mar 31, 2023	ONE68 GLOBAL CAPITAL, LLC	0.01%	30.12K	10.2K	30.12K	+100.00%
Mar 31, 2023	STATE STREET CORP	0.01%	21.02K	7.12K	0	0
Mar 31, 2023	WARBERG ASSET MANAGEMENT LLC	0.01%	20K	6.77K	20K	+100.00%
Mar 31, 2023	TWO SIGMA INVESTMENTS, LP	0.01%	19.41K	6.57K	0	0
Mar 31, 2023	SHAY CAPITAL LLC	0.01%	15.06K	5.1K	0	0
Mar 31, 2023	GOLDMAN SACHS GROUP INC	0%	13.12K	4.44K	-4K	-23.36%
Mar 31, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	6.35K	2K	0	0
Mar 31, 2023	WELLS FARGO & COMPANY/MN	0%	51	17	1	+2.00%
Mar 31, 2023	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	0%	0	-	0	0
Mar 31, 2023	RENAISSANCE TECHNOLOGIES LLC	0%	0	-	-13.5K	-100.00%

Insiders

Among the RNAZ insiders holding of 0.15% of the stake in company, DUDLEY ROBERT MICHAEL, Chief Executive Officer, holds the largest shares of 180.26K. FITZGERALD THOMAS A, Chief Financial Officer, is the second largest RNAZ insider with ownership of 56.32K shares. , , stands third with possession of - shares of that stake.

Insiders	Designation	Shares Held
DUDLEY ROBERT MICHAEL	Chief Executive Officer	180.26K
FITZGERALD THOMAS A	Chief Financial Officer	56.32K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Sep 28, 2023	FITZGERALD THOMAS A	PURCHASE	0.51	49.35K	25.17K	56.32K
Sep 28, 2023	DUDLEY ROBERT MICHAEL	PURCHASE	0.51	98K	49.98K	180.26K
Jun 21, 2023	DUDLEY ROBERT MICHAEL	PURCHASE	2.65	12K	31.82K	82.26K
Jun 20, 2023	DUDLEY ROBERT MICHAEL	PURCHASE	2.55	6.61K	16.85K	70.26K
Jun 09, 2023	DUDLEY ROBERT MICHAEL	PURCHASE	2.76	19K	52.44K	912.11K
Sep 14, 2022	DUDLEY ROBERT MICHAEL	PURCHASE	1.15	20K	23K	893.11K
Jun 16, 2022	FITZGERALD THOMAS A	PURCHASE	1.27	12K	15.24K	139.38K
May 27, 2022	DUDLEY ROBERT MICHAEL	PURCHASE	1.84	28K	51.64K	871.11K

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.